New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis

著者: Etxeberria, Iñaki, Glez-Vaz, Javier, Teijeira, Álvaro, Melero, Ignacio
出版年 ESMO Open (2020)

Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms

著者: Etxeberria, Iñaki, Olivera, Irene, Bolaños, Elixabet, Cirella, Asunta, Teijeira, Álvaro, Berraondo, Pedro, Melero, Ignacio
出版年 Cell Mol Immunol (2020)

Cellular immunotherapies for cancer

著者: Berraondo, Pedro, Labiano, Sara, Minute, Luna, Etxeberria, Iñaki, Vasquez, Marcos, Sanchez-Arraez, Alvaro, Teijeira, Alvaro, Melero, Ignacio
出版年 Oncoimmunology (2017)

Cytokines in clinical cancer immunotherapy

著者: Berraondo, Pedro, Sanmamed, Miguel F., Ochoa, María C, Etxeberria, Iñaki, Aznar, Maria A., Pérez-Gracia, José Luis, Rodríguez-Ruiz, María E., Ponz-Sarvise, Mariano, Castañón, Eduardo, Melero, Ignacio
出版年 Br J Cancer (2018)

Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death

著者: Otano, Itziar, Alvarez, Maite, Minute, Luna, Ochoa, María Carmen, Migueliz, Itziar, Molina, Carmen, Azpilikueta, Arantza, de Andrea, Carlos E., Etxeberria, Iñaki, Sanmamed, Miguel F., Teijeira, Álvaro, Berraondo, Pedro, Melero, Ignacio
出版年 Theranostics (2020)

Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15

著者: Ochoa, Maria Carmen, Minute, Luna, López, Ascensión, Pérez-Ruiz, Elisabeth, Gomar, Celia, Vasquez, Marcos, Inoges, Susana, Etxeberria, Iñaki, Rodriguez, Inmaculada, Garasa, Saray, Mayer, Jan-Peter Andreas, Wirtz, Peter, Melero, Ignacio, Berraondo, Pedro
出版年 Oncoimmunology (2017)

Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

著者: Azpilikueta, Arantza, Bolaños, Elixabet, Lang, Valerie, Labiano, Sara, Aznar, Maria A., Etxeberria, Iñaki, Teijeira, Alvaro, Rodriguez-Ruiz, Maria E., Perez-Gracia, Jose L., Jure-Kunkel, Maria, Zapata, Juan M., Rodriguez, Manuel S., Melero, Ignacio
出版年 Oncoimmunology (2017)

Repurposing the yellow fever vaccine for intratumoral immunotherapy

著者: Aznar, Maria Angela, Molina, Carmen, Teijeira, Alvaro, Rodriguez, Inmaculada, Azpilikueta, Arantza, Garasa, Saray, Sanchez‐Paulete, Alfonso R, Cordeiro, Luna, Etxeberria, Iñaki, Alvarez, Maite, Rius‐Rocabert, Sergio, Nistal‐Villan, Estanislao, Berraondo, Pedro, Melero, Ignacio
出版年 EMBO Mol Med (2019)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

著者: Aznar, M. Angela, Planelles, Lourdes, Perez-Olivares, Mercedes, Molina, Carmen, Garasa, Saray, Etxeberría, Iñaki, Perez, Guiomar, Rodriguez, Inmaculada, Bolaños, Elixabet, Lopez-Casas, Pedro, Rodriguez-Ruiz, Maria E., Perez-Gracia, Jose L., Marquez-Rodas, Ivan, Teijeira, Alvaro, Quintero, Marisol, Melero, Ignacio
出版年 J Immunother Cancer (2019)

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes

著者: Labiano, Sara, Meléndez-Rodríguez, Florinda, Palazón, Asís, Teijeira, Álvaro, Garasa, Saray, Etxeberria, Iñaki, Aznar, M. Ángela, Sánchez-Paulete, Alfonso R., Azpilikueta, Arantza, Bolaños, Elixabet, Molina, Carmen, de la Fuente, Hortensia, Maiso, Patricia, Sánchez-Madrid, Francisco, de Landázuri, Manuel Ortiz, Aragonés, Julián, Melero, Ignacio
出版年 Oncoimmunology (2017)

Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic

著者: Etxeberria, Iñaki, Bolaños, Elixabet, Teijeira, Alvaro, Garasa, Saray, Yanguas, Alba, Azpilikueta, Arantza, Kavanaugh, William M., Vasiljeva, Olga, Belvin, Marcia, Howng, Bruce, Irving, Bryan, Tipton, Kimberly, West, James, Mei, Li, Korman, Alan J., Sega, Emanuela, Olivera, Irene, Cirella, Assunta, Ochoa, Maria C., Rodriguez, Maria E., Melero, Ana, Sanmamed, Miguel F., Engelhardt, John J., Melero, Ignacio
出版年 Proc Natl Acad Sci U S A (2021)